ClinicalTrials.Veeva

Menu

The Effects of rTMS and tDCS Copuled With Robotic Therapy In Patients With Stroke

G

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Status

Unknown

Conditions

Chronic Stroke

Treatments

Other: active tDCS
Other: sham tDCS
Other: sham rTMS
Other: active rTMS

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to assess the effect of rTMS and tDCS coupled with robotic therapy on upper extremity functional recovery

Full description

After being informed about study and potential risks, all patient giving written informed consent will undergo screening period determine eligibility for study entry. The patients who meet the eligibility requirements will be randomized into four groups in a 1:1 ratio to active rTMS, sham rTMS, active tDCS and sham tDCS.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ischemic stroke with a disease interval of 6 months to 2 years
  • aged based 18 years
  • first stroke
  • Mini mental test score ≥ 22
  • upper extremity (elbow, wrist and finger) spasticity level Modified Ashworth Scale (MAS)≤2
  • Shoulder, elbow and wrist muscle strength ≥ 2 according to Medical Research Council- MRC

Exclusion criteria

  • hemorrhagic stroke
  • history of epilepsy
  • a cardiac pacemaker
  • pregnancy
  • Fugl Meyer upper extremity assessment score ≥44
  • history of previous stroke or ischemic attack
  • neurological diseases other than stroke
  • metallic implant in brain or scalp (including cochlear implant)
  • previous brain surgery
  • orthopedic disease that prevents upper extremity movements
  • diagnosis of malignancy
  • receiving robotic /TMS/tDCS treatments in the last 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 4 patient groups

active rTMS
Experimental group
Description:
Participants recevied 1 Hz low frequency repetetive TMS during 20 minutes and a total of 1200 stimuli for 15 sessions. The patient received robotic therapy for upper extremity just after each active TMS sessions
Treatment:
Other: active rTMS
sham rTMS
Sham Comparator group
Description:
Participants recevied sham TMS during 20 minutes and a total of 1200 sham stimuli for 15 sessions with sham coil. The patient received robotic therapy for upper extremity just after each sham TMS sessions
Treatment:
Other: sham rTMS
active tDCS
Experimental group
Description:
Participants recevied 2 mA anodal transcranial direct current stimulation 20 minutes for 15 sessions. The patient received robotic therapy for upper extremity just after each active tDCS sessions
Treatment:
Other: active tDCS
sham tDCS
Sham Comparator group
Description:
Participants recevied sham stimulation. The patient received robotic therapy for upper extremity just after each sham tDCS sessions
Treatment:
Other: sham tDCS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems